Assuntos: TERAPIAS COMPLEMENTARES, FATORES BIOLÓGICOS, ESPONDILITE ANQUILOSANTE
ABNT
SHIMABUCO, Andrea Y. et al. Sulfasalazine Comedication: A Predictor of Reduced Long-Term Anti-TNF Switch in Ankylosing Spondylitis. . Atlanta: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf. Acesso em: 23 maio 2024. , 2015APA
Shimabuco, A. Y., Gonçalves, C. R., Moraes, J. C. B., Waisberg, M. G., Sampaio-Barros, P. D., Goldenstein-Schainberg, C., et al. (2015). Sulfasalazine Comedication: A Predictor of Reduced Long-Term Anti-TNF Switch in Ankylosing Spondylitis. Atlanta: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/art.39448NLM
Shimabuco AY, Gonçalves CR, Moraes JCB, Waisberg MG, Sampaio-Barros PD, Goldenstein-Schainberg C, Bonfá E, Saad CGS. Sulfasalazine Comedication: A Predictor of Reduced Long-Term Anti-TNF Switch in Ankylosing Spondylitis [Internet]. 2015 ; 67( S10):[citado 2024 maio 23 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdfVancouver
Shimabuco AY, Gonçalves CR, Moraes JCB, Waisberg MG, Sampaio-Barros PD, Goldenstein-Schainberg C, Bonfá E, Saad CGS. Sulfasalazine Comedication: A Predictor of Reduced Long-Term Anti-TNF Switch in Ankylosing Spondylitis [Internet]. 2015 ; 67( S10):[citado 2024 maio 23 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf